Isaura Santos graduated with a BS in Cell and Molecular Biology from Universidade Nova de Lisboa and a MA in Communication, Culture and Information Technologies from University Institute of Lisbon (ISCTE-IUL). Her professional interests include science communication, public awareness of science and communication of science through entertainment.
Children suffering from inflammatory bowel disease (IBD) who are reacting positively to prescribed biological medications should not have their prescriptions changed to recently approved “biosimilar” ... Read more
TxCell SA is a biotechnology firm advancing innovative and personalized T cell immunotherapies utilizing antigen specific regulatory T-cells (Ag-Tregs) to address both severe chronic inflammatory ... Read more
Qu Biologics Inc., a biotechnology firm currently developing Site Specific Immunomodulators (SSIs) to restore regular immune function in a specific targeted diseased organ, recently announced ... Read more